TOP NEWS

Xencor Names New Board Member

Monrovia-based biopharmaceuticals firm Xencor announced this morning that it has added A. Bruce Montgomery, M.D., to its board of directors. Montgomery is currently the CEO of Cardeas Pharma, and was a SVP at Gilead Sciences; he also was CEO of Corus Pharma, and served at PathoGenesis Corporation. Xencor is developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer.


LATEST HEADLINES

More Headlines

BROWSE ISSUES